Inactive Instrument

Analyst Reco. Bone Therapeutics SA Euronext Bruxelles

Equities

End-of-day quote Euronext Bruxelles Other stock markets
-	-

04-11	Biosenic: launch of a debt restructuring plan	CF
03-12	Biosenic S.A. Releases Details of Optimized Administration Approach Ahead of Planned Phase 3 Trial of OATO for Chronic Graft-Versus-Host Disease	CI

ANALYST RECOMMENDATIONS : AT&T, BancorpSouth Bank, CMO Group, Magnite, Textron...	21-08-31
Bone Therapeutics Allogeneic Cell Therapy Product, ALLOB, Shows 90% Fusion Rate at 24 Months in Phase IIa Study in Lumbar Spinal Fusion	20-10-14	CI

No results for this search